Search
Menu
Home
HTB
2019
May
May 2019
Contents
Editorial
HTB 20 May 2019: vol 20 no 6 – conference reports and PARTNER 2 published in The Lancet
Conference reports
13th INTEREST workshop 14–17 May 2019, Accra, Ghana
No increased adverse outcomes among women starting dolutegravir before conception in the ADVANCE study
25th Annual BHIVA Conference (BHIVA 2019)
Fifty new HIV diagnoses at Dean Street linked to caps on IMPACT study
Management of testosterone deficiency in HIV positive people
Importance of including menopause and bone health in management of HIV positive women
Type 2 diabetes is often undermanaged in HIV positive people
Adopting new US blood pressure targets for HIV positive people could reduce cardiovascular-related deaths
Selected webcasts from BHIVA 2019
Conference on Retroviruses and Opportunistic Infections (CROI 2019) 4–7 March, 2019
INSTI and weight gain: reports from CROI 2019
B/F/TAF suitable for children from six years of age
HIV prevention and transmission
PARTNER 2 study published in the Lancet: global news coverage that ART stops HIV transmission
PDFs
20 May 2019 vol 20 no 6
HTB RSS
Early access
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate